Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Vitamin D
100%
Musculoskeletal Symptoms
100%
Placebo-controlled Randomized Trial
100%
Aromatase Inhibitors
100%
Placebo
50%
Bone Mineral Density
50%
Fibromyalgia Impact Questionnaire
50%
25-hydroxyvitamin D (25OHD)
33%
Placebo Groups
16%
Placebo-controlled
16%
Breast Cancer Patients
16%
High Dose
16%
Vitamin D Supplementation
16%
Randomized Phase II Trial
16%
Vitamin D2
16%
Early Breast Cancer
16%
Bone Loss
16%
Baseline Characteristics
16%
Pain Severity
16%
Change from Baseline
16%
Femoral Neck
16%
Musculoskeletal Pain
16%
Bone Health
16%
Anastrozole
16%
Percent Change
16%
Brief Pain Inventory-Short Form
16%
Cancer Inhibitors
16%
Supplementation Strategies
16%
Health Assessment Questionnaire Disability Index (HAQ-DI)
16%
Medicine and Dentistry
Placebo
100%
Randomized Controlled Trial
100%
Musculoskeletal Disease
100%
Vitamin D
100%
Aromatase Inhibitor
100%
Bone Density
50%
Fibromyalgia Impact Questionnaire
50%
Breast Cancer
33%
Supplementation
33%
Drug Megadose
16%
Osteolysis
16%
Femoral Neck
16%
Musculoskeletal Pain
16%
Phase II Trials
16%
Anastrozole
16%
Ergocalciferol
16%
Brief Pain Inventory
16%
Health Assessment Questionnaire
16%
Artificial Intelligence
16%
Pharmacology, Toxicology and Pharmaceutical Science
Placebo
100%
Randomized Controlled Trial
100%
Vitamin D
100%
Musculoskeletal Disease
100%
Aromatase Inhibitor
100%
Fibromyalgia
50%
Breast Cancer
33%
Ergocalciferol
16%
Phase II Trials
16%
Musculoskeletal Pain
16%
Anastrozole
16%